FDA product code LJB: Enzyme Linked Immunoabsorbent Assay, Rubeola Igg
LJB is the FDA product code for enzyme linked immunoabsorbent assay, rubeola igg. It is a Class I device, regulated under 21 CFR 866.3520 and reviewed by the Microbiology panel. FDA has cleared 11 510(k) submissions under LJB, from 8 different applicants. The average 510(k) review took 121 days (median 112). FDA has posted 7 recalls for LJB devices, 2 initiated in the last five years.
Definition
The qualitative detection of measles specific IgG antibodies in serum or plasma.
Classification
| Field | Value |
|---|---|
| Device name | Enzyme Linked Immunoabsorbent Assay, Rubeola Igg |
| Device class | Class I |
| Regulation | 21 CFR 866.3520 |
| Review panel | MI — Microbiology |
| Medical specialty | Microbiology |
| Premarket route | 510(k) exempt |
Compare with all 510(k) review times · Search every LJB clearance
Top LJB applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Diamedix Corp. | 2 | 1998-01-28 |
| Baxter Diagnostics, Inc. | 2 | 1992-09-02 |
| Gull Laboratories, Inc. | 2 | 1991-01-03 |
| Inova Diagnostics, Inc. | 1 | 1997-07-22 |
| Virus Reference Laboratory, Inc. | 1 | 1992-03-18 |
3 more applicants have LJB clearances. See the full list in Caduvo.
Most recent LJB clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K974552 | Diamedix Corp. | DIAMEDIX IS-MEASLES IGG TEST SYSTEM | 1998-01-28 | 55 |
| K971620 | Inova Diagnostics, Inc. | QUANTA LITE RUBEOLA (MEASLES) IGG | 1997-07-22 | 82 |
| K922330 | Baxter Diagnostics, Inc. | BARTELS RUBEOLA IGG EIA | 1992-09-02 | 112 |
| K922335 | Baxter Diagnostics, Inc. | BARTELS RUBEOLA IGM EIA | 1992-09-02 | 112 |
| K910290 | Virus Reference Laboratory, Inc. | VIRATEST-DIA(TM) MEASLES (RUBEOLA) | 1992-03-18 | 421 |
Recalls for LJB devices
7 product recalls in 6 recall events; 2 initiated in the last five years and 3 still open. Most recent: 2025-10-01.
| Year | Recalls |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 1 |
Frequently asked questions
What is FDA product code LJB?
LJB is the FDA product code for enzyme linked immunoabsorbent assay, rubeola igg. It is a Class I device, regulated under 21 CFR 866.3520 and reviewed by the Microbiology panel.
What device class is LJB?
Class I, regulation 21 CFR 866.3520. Typical premarket route: 510(k) exempt.
How long does a 510(k) take for product code LJB?
Across 11 cleared submissions the average was 121 days from receipt to decision (median 112).
Which companies have the most LJB clearances?
Diamedix Corp. (2); Baxter Diagnostics, Inc. (2); Gull Laboratories, Inc. (2); Inova Diagnostics, Inc. (1); Virus Reference Laboratory, Inc. (1).
Have LJB devices been recalled?
Yes: 7 product recalls across 6 recall events; the most recent began 2025-10-01.
Next steps
- Run an FDA pathway report with predicate devices for product code LJB
- Run a recall and safety report across every LJB manufacturer
- Watch product code LJB for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Microbiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times